# The Human Microbiome

Canonical URL: https://shipslides.com/d/health-microbiome
Raw viewer URL: https://content.shipslides.com/d/health-microbiome/raw
Category: Health
Slides: 12
Updated: 2026-05-17T20:51:43.662Z
Tags: health, microbiome

## Summary

The Hidden Ecosystem Within Us Key sections include: The Human Microbiome; By the Numbers; Body Sites and Their Communities; How We Acquire Our Microbiome; The Gut-Brain Axis; Immunity and the Microbiome; Metabolism and Obesity; The Microbiome and Disease; Therapeutic Approaches; Research Methods.

## Slide Outline

1. The Human Microbiome
2. By the Numbers
3. Body Sites and Their Communities
4. How We Acquire Our Microbiome
5. The Gut-Brain Axis
6. Immunity and the Microbiome
7. Metabolism and Obesity
8. The Microbiome and Disease
9. Therapeutic Approaches
10. Research Methods
11. The Disappearing Microbiome
12. The Future of Microbiome Medicine

## Slide Transcript

### Slide 1: The Human Microbiome

- The Hidden Ecosystem Within Us
- You are not one organism. You are an ecosystem. The human body harbors approximately 38 trillion microbial cells -- bacteria, archaea, fungi, and viruses -- slightly outnumbering your own 30 trillion human cells. This community, the microbiome, collectively encodes 150 times more genes than the human genome. These microbes are not passengers or parasites: they are essential collaborators in digestion, immunity, metabolism, and even brain function. Understanding the microbiome is rewriting our understanding of human health, disease, and what it means to be an individual organism.

### Slide 2: By the Numbers

- Scale
- 38 trillion
- Microbial cells in the human body (revised estimate, 2016). Previous claims of "10:1 microbes to human cells" were overestimated, but the current ratio (~1.3:1) still means microbial cells slightly outnumber human cells. By genetic content, the disparity is extreme: the human genome has ~20,000 genes; the microbiome collectively has ~3.3 million protein-coding genes -- a genetic repertoire 150x larger than our own.
- Diversity
- 1,000+
- Bacterial species identified in the human gut. Each individual typically harbors 150-200 species. Species composition varies dramatically between individuals -- your gut microbiome is more unique to you than your fingerprint. Most dominant phyla: Firmicutes and Bacteroidetes (together comprising 90%+ of gut bacteria), plus Actinobacteria, Proteobacteria, and Verrucomicrobia.
- Mass
- 1.5-2 kg
- Total microbial mass in an adult human -- comparable to the brain's weight. Most concentrated in the colon (~100 billion bacteria per gram of content). The small intestine, skin, mouth, respiratory tract, and urogenital tract each host distinct communities adapted to their local environments (pH, oxygen levels, nutrients, temperature).

### Slide 3: Body Sites and Their Communities

- The Gut (Large Intestine)
- The body's most densely colonized environment: 100 billion bacteria per gram. An anaerobic (oxygen-free) ecosystem where bacteria ferment dietary fiber into short-chain fatty acids (SCFAs: butyrate, propionate, acetate) that feed intestinal cells, regulate immune function, and influence metabolism. The gut microbiome performs functions human cells cannot: breaking down complex plant polysaccharides, synthesizing vitamins (K, B12, folate), and metabolizing drugs and dietary compounds into bioactive metabolites.
- The Skin
- The body's largest organ hosts ~1,000 bacterial species adapted to distinct micro-environments: oily (forehead, back -- dominated by Cutibacterium), moist (armpit, groin -- dominated by Staphylococcus and Corynebacterium), and dry (forearm, leg -- most diverse). The skin microbiome provides colonization resistance against pathogens, trains local immunity, and influences body odor. Each person's skin microbiome is unique enough for forensic identification.
- The Oral Cavity
- The mouth harbors the second most diverse community: ~700 species across distinct niches (tongue, teeth, gums, palate, tonsils). Dental plaque is a structured biofilm -- one of the most studied microbial communities. Oral bacteria like Streptococcus mutans cause dental caries by producing acid from sugar. Conversely, some oral bacteria reduce dietary nitrate to nitrite, contributing to cardiovascular health through nitric oxide production.
- The Vaginal Microbiome
- Unusually low diversity compared to other sites: dominated by Lactobacillus species in most healthy women. Lactobacilli produce lactic acid (maintaining low pH ~3.8-4.5) and hydrogen peroxide, creating a hostile environment for pathogens. Bacterial vaginosis -- a shift away from Lactobacillus dominance toward diverse anaerobes -- increases susceptibility to STIs and adverse pregnancy outcomes. The vaginal microbiome during birth is the newborn's first microbial exposure.

### Slide 4: How We Acquire Our Microbiome

- Birth and Early Life
- Newborns are colonized during and immediately after birth. Delivery mode matters enormously: vaginal birth exposes infants to maternal vaginal and fecal microbiota (Lactobacillus, Bacteroides), while cesarean delivery results in colonization by skin and hospital environment bacteria (Staphylococcus, Streptococcus). C-section-born infants show altered microbiome development for months to years, with potential health implications (higher rates of allergy, asthma, obesity in epidemiological studies -- though causality remains debated).
- Breastmilk contains ~700 bacterial species plus human milk oligosaccharides (HMOs) -- complex sugars indigestible by infants but selectively feeding beneficial Bifidobacteria. Formula-fed infants develop different microbial communities. By age 2-3, the microbiome reaches adult-like complexity and stability.
- Lifelong Influences
- Diet: The strongest modifiable factor. High-fiber diets promote diverse Firmicutes that produce beneficial SCFAs. Western diets (high fat, low fiber, high processed food) reduce diversity and increase Proteobacteria associated with inflammation.
- Antibiotics: A single course can eliminate 30%+ of gut species. Some recover; others are permanently lost. Repeated antibiotic exposure (common in childhood) may deplete ancestral microbes irreversibly.
- Geography and culture: Hunter-gatherer populations (Hadza, Yanomami) harbor far greater microbial diversity than industrialized populations. Microbes lost through industrialization may be gone forever from modern humans.
- Aging: Elderly microbiomes show reduced diversity and altered composition, correlating with frailty and inflammation.

### Slide 5: The Gut-Brain Axis

- One of the most surprising discoveries: gut microbes communicate bidirectionally with the brain, influencing mood, behavior, cognition, and neurological disease.
- Communication Pathways
- The vagus nerve provides a direct neural highway between gut and brain (cutting it abolishes some microbiome-brain effects in animal models). Microbial metabolites enter the bloodstream and cross the blood-brain barrier. The immune system relays inflammatory signals from gut to brain. Gut bacteria produce neurotransmitters (95% of the body's serotonin is made in the gut, though by intestinal cells influenced by bacteria). These multiple pathways create a complex signaling network between microbiome and brain.
- Mental Health Connections
- Germ-free mice (raised without any microbes) show altered anxiety, social behavior, and stress responses -- reversible by microbial colonization, but only if done during a critical developmental window. In humans, observational studies link gut microbiome composition to depression, anxiety, autism spectrum conditions, and schizophrenia. Probiotic interventions show modest but real effects on mood in some clinical trials ("psychobiotics"). Causality is difficult to establish, but the associations are compelling and replicable.
- Neurological Disease
- Parkinson's disease patients show altered gut microbiomes years before motor symptom onset -- gut dysfunction and constipation often precede diagnosis by a decade, suggesting disease may start in the gut. Alzheimer's disease is associated with specific microbial metabolites that promote neuroinflammation. Multiple sclerosis patients have distinct gut microbiome profiles. These associations don't yet prove causation, but they suggest therapeutic avenues: could modifying the microbiome slow neurodegeneration?

### Slide 6: Immunity and the Microbiome

- Training the Immune System
- The microbiome educates the immune system from birth -- teaching it to distinguish harmless colonizers from dangerous pathogens. Germ-free animals have severely underdeveloped immune systems: fewer T cells, reduced antibody production, smaller spleens and lymph nodes. Specific bacterial species induce specific immune cell populations: Bacteroides fragilis promotes anti-inflammatory regulatory T cells; segmented filamentous bacteria (SFB) induce pro-inflammatory Th17 cells needed for pathogen defense.
- The "hygiene hypothesis" (now called "old friends" or "biodiversity" hypothesis): reduced microbial exposure in modern environments may explain rising rates of autoimmune diseases, allergies, and inflammatory conditions. Our immune system evolved to manage a diverse microbial ecosystem -- remove that diversity, and immune regulation goes awry.
- Colonization Resistance
- A healthy microbiome prevents pathogen establishment through multiple mechanisms: competing for nutrients and attachment sites, producing antimicrobial compounds (bacteriocins), maintaining conditions (pH, oxygen levels) inhospitable to invaders, and stimulating mucosal immunity. Antibiotic disruption of this "colonization resistance" explains why Clostridioides difficile infection often follows antibiotic courses -- the protective community is eliminated, leaving the niche open for this dangerous pathogen.

### Slide 7: Metabolism and Obesity

- Calorie Harvest
- Gut bacteria extract additional calories from food that human enzymes cannot digest -- primarily through fiber fermentation into SCFAs (~10% of daily caloric intake comes from microbial metabolism). Different microbiome compositions extract different amounts of energy from identical diets. The landmark 2006 study (Turnbaugh et al.) showed that transplanting obese mice's microbiomes into germ-free recipients caused weight gain -- even on identical diets. The microbiome is not just correlating with obesity; it's mechanistically contributing.
- The Firmicutes/Bacteroidetes Ratio
- Early research found obese individuals had higher Firmicutes-to-Bacteroidetes ratios. This oversimplification has been nuanced -- the relationship is real but less binary than initially proposed. Specific taxa (Akkermansia muciniphila, Christensenellaceae) consistently associate with leanness and metabolic health across populations. The microbiome influences fat storage, insulin sensitivity, satiety signaling, and inflammatory state -- all relevant to metabolic disease.
- Personalized Nutrition
- The same food produces different blood glucose responses in different people -- partly explained by microbiome differences. The Weizmann Institute's landmark 2015 study (800 participants, continuous glucose monitoring) showed that microbiome composition predicted individual glycemic responses better than food composition alone. This implies diets should be personalized based on an individual's microbiome rather than applying universal dietary recommendations.

### Slide 8: The Microbiome and Disease

- Inflammatory Bowel Disease (IBD)
- Crohn's disease and ulcerative colitis involve disrupted host-microbiome relationships. Patients show reduced microbial diversity, loss of beneficial butyrate-producing bacteria (Faecalibacterium prausnitzii), and overgrowth of adherent-invasive E. coli. Genetics (NOD2, ATG16L1 mutations) affect how the immune system interacts with bacteria. IBD likely results from inappropriate immune responses to normal microbiota in genetically susceptible individuals.
- Cancer
- Specific bacteria promote certain cancers: Helicobacter pylori (gastric cancer -- the only bacterium classified as a definite carcinogen), Fusobacterium nucleatum (colorectal cancer -- found in tumors, promotes growth). The microbiome also influences cancer treatment response: immunotherapy (checkpoint inhibitors) works better in patients with specific gut bacteria (Akkermansia muciniphila, Bifidobacterium). Antibiotics before immunotherapy reduce treatment efficacy -- a microbiome-dependent effect with immediate clinical implications.
- Cardiovascular Disease
- Gut bacteria metabolize dietary choline, carnitine, and betaine (found in red meat, eggs, dairy) into trimethylamine (TMA), which the liver converts to TMAO -- a compound strongly associated with atherosclerosis and cardiovascular events in humans. Vegetarians produce less TMAO from the same substrates because they lack the TMA-producing bacteria. This suggests one mechanism through which diet, microbiome, and heart disease interact -- and a potential therapeutic target.
- Type 2 Diabetes
- Diabetic patients consistently show reduced microbial diversity and specific compositional changes: fewer butyrate producers, more opportunistic pathogens. Metformin (first-line diabetes drug) partly works through the microbiome -- it enriches Akkermansia muciniphila, which strengthens the gut barrier and reduces inflammation. Some of metformin's GI side effects are microbiome-mediated. Understanding these interactions could enable microbiome-optimized drug dosing.

### Slide 9: Therapeutic Approaches

- Fecal Microbiota Transplantation (FMT)
- Transferring stool from a healthy donor to a patient's gut -- the most dramatic microbiome intervention. Extraordinarily effective for recurrent C. difficile infection: 85-90% cure rate (vs. 30% for antibiotics alone). Approved by FDA for this indication. Under investigation for IBD, metabolic syndrome, and autism -- with more mixed results. The crude "ecosystem transplant" approach may be replaced by defined communities of cultured bacteria as mechanistic understanding improves.
- Probiotics
- Live microorganisms intended to confer health benefits. Evidence strongest for specific strains in specific conditions: Lactobacillus rhamnosus GG for antibiotic-associated diarrhea; VSL#3 for ulcerative colitis maintenance; Bifidobacterium infantis for irritable bowel syndrome. Most commercial probiotics lack rigorous evidence for their marketing claims. Key limitation: introduced bacteria rarely colonize permanently -- they transit through without establishing residence, providing transient effects at best.
- Prebiotics and Diet
- Feeding your existing microbiome rather than introducing new organisms. Dietary fiber (inulin, FOS, resistant starch) selectively nourishes beneficial bacteria that produce anti-inflammatory SCFAs. The Mediterranean diet's health benefits are partly microbiome-mediated: high fiber, polyphenols, and fermented foods promote microbial diversity and beneficial metabolite production. Dietary change can shift microbiome composition within 24-48 hours -- though stable shifts require sustained dietary change.
- Next-Generation Therapeutics
- Defined microbial consortia (specific, characterized strains in precise combinations) rather than crude FMT. Engineered bacteria (synthetic biology) programmed to produce therapeutic molecules in the gut. Postbiotics (microbial metabolites delivered directly without live organisms). Phage therapy (viruses targeting specific harmful bacteria without antibiotic resistance concerns). These approaches offer precision the crude probiotic and FMT approaches lack.

### Slide 10: Research Methods

- 16S rRNA Sequencing
- The workhorse of microbiome research. The 16S ribosomal RNA gene is present in all bacteria, with conserved regions (for universal PCR amplification) and variable regions (for species identification). Sequencing this gene from a sample identifies which bacteria are present and their relative abundances. Cheap and well-established but limited: identifies bacteria only to genus level, misses viruses and fungi, and provides no functional information (what bacteria are doing).
- Shotgun Metagenomics
- Sequencing all DNA in a sample -- providing species-level resolution, functional gene content, and detection of viruses, fungi, and archaea. More expensive and computationally intensive than 16S. Reveals what the community can do (gene content) but not what it is doing at any given moment. Combined with metatranscriptomics (RNA sequencing) reveals active gene expression, and metabolomics reveals actual metabolic output.
- The challenge of causation: Most microbiome studies are correlational -- showing associations between microbial composition and health outcomes without proving causation. Establishing causation requires interventional studies (randomized controlled trials of microbiome modification), gnotobiotic animal models (germ-free mice colonized with specific communities), and mechanistic evidence (identifying specific microbial metabolites and their molecular targets). The field is transitioning from correlation to mechanism, but the complexity is enormous.

### Slide 11: The Disappearing Microbiome

- The "Missing Microbes" Hypothesis
- Martin Blaser's thesis: modern practices -- antibiotics, cesarean delivery, formula feeding, hyper-hygiene, processed food -- are systematically eliminating bacterial species from the human microbiome that have been our partners for millions of years. Some losses may be permanent: if a species is eliminated from all members of a community, vertical transmission from parent to child is broken forever. The Hadza of Tanzania harbor 40%+ more microbial diversity than urban Westerners. We may be losing microbes we don't even know we need.
- Health Consequences
- Blaser argues this microbial impoverishment explains the modern epidemic of immune and metabolic diseases: asthma (300% increase since 1960s), food allergies (50% increase in children since 1997), type 1 diabetes (3-5% annual increase), obesity, IBD, autism. Helicobacter pylori -- present in nearly all humans historically, now absent from most Western stomachs due to antibiotics -- protected against esophageal cancer, asthma, and allergies despite causing ulcers. We eliminated it without understanding the trade-off.

### Slide 12: The Future of Microbiome Medicine

- Precision Microbiome Medicine
- Just as genomics enables precision medicine based on individual genetics, microbiome profiling could enable personalized therapeutic approaches. Your specific microbial community determines how you respond to drugs, foods, and pathogens. Future clinicians may prescribe microbiome modifications -- targeted probiotics, dietary interventions, or defined microbial therapeutics -- based on individual microbiome characterization alongside traditional diagnostics.
- Microbiome Biomarkers
- Microbiome signatures may enable early disease detection before symptoms appear. Colorectal cancer screening from stool microbiome profiles (Fusobacterium enrichment). Depression risk from gut bacterial composition. Liver disease staging from oral microbiome changes. These non-invasive biomarkers could complement or replace invasive diagnostic procedures and enable earlier intervention.
- Synthetic Ecology
- Rather than transplanting uncharacterized communities (FMT) or single strains (probiotics), future interventions will use precisely defined, engineered microbial ecosystems designed for specific therapeutic goals. Synthetic biology enables programming bacteria to produce specific metabolites, sense disease biomarkers, and respond to environmental signals. We are moving from the "gardening" era (tend what's there) to the "engineering" era (design what should be there).
- The microbiome revolution has fundamentally changed how we understand human biology. We are not autonomous organisms but holobionts -- composite entities whose health depends on the health of our microbial partners. Medicine that ignores the microbiome is incomplete. Diet that ignores microbial nutrition is misguided. Health that ignores our inner ecosystem is fragile. The next generation of healthcare will treat the whole ecosystem, not just the human host.


## Related Decks

- [The Science of Sleep](https://shipslides.com/d/health-sleep-science)
- [Dental Health](https://shipslides.com/d/health-dental-health)
- [Epidemiology](https://shipslides.com/d/health-epidemiology)
- [Exercise Physiology](https://shipslides.com/d/health-exercise-physiology)